Sandoz Inc., a global leader in generic pharmaceuticals and biosimilars, announced that the US Food and Drug Administration has approved Symjepi (epinephrine) 0.15 mg injection for the emergency treatment of allergic reactions in children.
Ook interessant voor je
Reageer